Want to join the conversation?
Biopharmaceutical companies $SPPI & Onxeo S.A. announced Phase 1 results of drug belinostat (Beleodaq) with the CHOP chemotherapy regimen as a first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL), a type of blood cancer. Study shows 86% response rate with 67% complete responses in patients with PTCL.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.